Pegylated interleukin-2 (Chiron)

N/A

Report date: 2022/01/24 13:25:20

Base Information

Drug NamePegylated interleukin-2 (Chiron)
Drug Alias Name聚乙二醇化白细胞介素-2-ChironPEG-interleukin-2PEG-IL-2
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasm MetastasisSquamous Cell Carcinoma of Head and NeckHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiron
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiron
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisSquamous Cell Carcinoma of Head and NeckHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A